Spyre Therapeutics Announces Pricing of Upsized $403.0 Million Public Offering of Common Stock [Yahoo! Finance]
Jefferies Financial Group Inc. (JEF)
Last jefferies financial group inc. earnings: 10/25 04:42 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
clinical-stage biotechnology company advancing best-in-class antibody engineering, dose optimization, and rational therapeutic combinations for the treatment of Inflammatory Bowel Disease (“IBD”) and other immune-mediated diseases, today announced the pricing of its previously announced underwritten public offering of 6,500,000 shares of its common stock at a price to the public of $62.00 per share. The gross proceeds to the Company from this offering are expected to be approximately $403.0 million, before deducting underwriting discounts and commissions and other offering expenses. In addition, the Company has granted the underwriters of the offering an option for a period of 30 days to purchase up to an additional approximately $60.5 million of shares of the Company's common stock at the public offering price, less the underwriting discount. The offering is expected to close on or about April 16, 2026, subject to satisfaction of customary closing conditions. Jefferies LLC, Goldman
Show less
Read more
Impact Snapshot
Event Time:
JEF
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JEF alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JEF alerts
High impacting Jefferies Financial Group Inc. news events
Weekly update
A roundup of the hottest topics
JEF
News
- Icade (CDMGF) Q1 2026 Sales/Trading Call Transcript [Seeking Alpha]Seeking Alpha
- Fuchs SE (FUPBY) Analyst/Investor Day Transcript [Seeking Alpha]Seeking Alpha
- Spyre Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $463.5 Million [Yahoo! Finance]Yahoo! Finance
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jefferies Financial Group Inc. - JEFPR Newswire
- Pluxee N.V. (PLXNF) Q2 2026 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
JEF
Earnings
- 3/25/26 - Miss
JEF
Sec Filings
- 4/17/26 - Form 424B2
- 4/17/26 - Form 424B2
- 4/16/26 - Form 424B2
- JEF's page on the SEC website